v2.4.0.8
Restructuring and Divestiture Charges - Additional Information (Detail) (USD $)
3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended
Sep. 28, 2013
Jun. 29, 2013
Mar. 30, 2013
Mar. 24, 2012
Sep. 24, 2011
Sep. 28, 2013
Sep. 29, 2012
Sep. 24, 2011
Sep. 29, 2012
Indiana [Member ]
Sep. 28, 2013
Indiana [Member ]
Sep. 28, 2013
Subsequent Event [Member]
Sep. 28, 2013
Restructuring [Member]
Sep. 29, 2012
Restructuring [Member]
Mar. 24, 2012
Abandonment of Adiana Product Line [Member]
Sep. 29, 2012
Abandonment of Adiana Product Line [Member]
Sep. 29, 2012
Consolidation of Diagnostics Operations [Member]
Sep. 28, 2013
Consolidation of Diagnostics Operations [Member]
Sep. 29, 2012
Consolidation of Diagnostics Operations [Member]
Sep. 28, 2013
Consolidation of Diagnostics Operations [Member]
Restructuring [Member]
Sep. 28, 2013
Site Closure Costs [Member]
Employees
Sep. 28, 2013
One-time Termination Benefits [Member]
Sep. 29, 2012
Other Operating Cost Reductions [Member]
Mar. 24, 2012
Other Operating Cost Reductions [Member]
Sep. 29, 2012
Closure of Indianapolis Facility [Member]
Sep. 28, 2013
Closure of Indianapolis Facility [Member]
Sep. 28, 2013
Closure of Indianapolis Facility [Member]
Restructuring [Member]
Sep. 28, 2013
Employee Severance [Member]
Restructuring Cost and Reserve [Line Items]                                                      
Divestiture charges       $ 18,300,000                   $ 18,300,000 $ 19,500,000                        
Restructuring charges - cost of product sales                             19,100,000                        
Other restructuring charges                             400,000                        
Impairment charges related to inventory                             9,900,000                        
Impairment charges related to manufacturing equipment                             6,500,000                        
Charges related to outstanding contractual obligations                             2,700,000                        
Severance charge   4,600,000     300,000           4,600,000       100,000 900,000 3,200,000 13,300,000 10,800,000   1,100,000 100,000   900,000   4,800,000 6,800,000
Restructuring charges not recorded in cost of product sales                             300,000                        
Stock-based compensation expense           52,307,000 40,572,000 35,472,000       9,029,000 3,500,000         3,500,000 6,300,000                
Employee retention program, payments in cash     9,700,000                                                
Estimated aggregate severance charges   5,200,000                             6,400,000               6,000,000    
Exiting charges                 900,000 800,000           600,000                      
Compensation charges                                                     1,400,000
Number of employees affected                                       100              
Impairment charges           7,667,000 16,901,000                         300,000              
Lease obligation charge and write-off of related leaseholds           400,000                                          
Charges related to termination of lease                                             400,000        
Impairment charges for assets held for sale 700,000         3,700,000 6,500,000                                        
Assets held for sale, sales value 3,000,000         3,000,000                                          
Assets held-for-sale inventory and equipment 2,400,000         2,400,000                                          
Assets held-for-sale Goodwill 600,000         600,000                                          
Gain on the sale of LIFECODES business     900,000                                                
Disposition charges           300,000                                          
Proceeds from sale of minor non-core product line         1,100,000                                            
Net gain on sale of minor non-core product line         $ 400,000